# Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs

> **NCT06600724** · NA · RECRUITING · sponsor: **MiMedx Group, Inc.** · enrollment: 170 (estimated)

## Conditions studied

- Diabetic Foot Ulcer
- Diabetic Foot
- Foot Ulcer Due to Type 2 Diabetes Mellitus
- Foot Ulcer, Diabetic
- Foot Ulcer

## Interventions

- **OTHER:** Standard of Care
- **OTHER:** EPIEFFECT
- **OTHER:** EPIXPRESS

## Key facts

- **NCT ID:** NCT06600724
- **Lead sponsor:** MiMedx Group, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-27
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06600724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06600724, "Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06600724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*